Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”Unfractionated heparin has been used for decades.
But using it well still requires careful clinical decisions.
When is UFH preferable to other anticoagulants?
Should treatment begin with a bolus?
When might a no – bolus strategy make more sense?
And how can the risks associated with UFH infusions be reduced?
At Thrombosis Unpacked: Decisions That Matter, Dr. Matthew Nicholson will take a modern look at this familiar anticoagulant in Unfractionated Heparin: Old Drug, Narrow Lane, focusing on where UFH still belongs in clinical practice and strategies to improve its safe use.
Join colleagues from across Canada to explore practical approaches to difficult thrombosis and anticoagulation decisions.
November 7, 2026 | Montréal.‘
Other posts featuring Thrombosis Canada on Hemostasis Today.
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury